Diabetes Metab J.  2023 Nov;47(6):859-868. 10.4093/dmj.2022.0377.

Prediabetes Progression and Regression on Objectively- Measured Physical Function: A Prospective Cohort Study

Affiliations
  • 1Department of General Practice, Institute of Diabetes, Zhongda Hospital, School of Medicine, Southeast University, Nanjing,
  • 2Research and Education Centre of General Practice, Zhongda Hospital, Southeast University, Nanjing,
  • 3Department of Endocrinology, Institute of Diabetes, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China
  • 4Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK
  • 5Department of Nursing Management, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China
  • 6Adelaide Medical School and Centre of Research Excellence (CRE) in Translating Nutritional Science to Good Health, The University of Adelaide, Adelaide, Australia

Abstract

Background
Prediabetes leads to declines in physical function in older adults, but the impact of prediabetes progression or regression on physical function is unknown. This study assessed this longitudinal association, with physical function objectivelymeasured by grip strength, walking speed, and standing balance, based on the Health and Retirement Study enrolling United States adults aged >50 years.
Methods
Participants with prediabetes were followed-up for 4-year to ascertain prediabetes status alteration (maintained, regressed, or progressed), and another 4-year to assess their impacts on physical function. Weak grip strength was defined as <26 kg for men and <16 kg for women, slow walking speed was as <0.8 m/sec, and poor standing balance was as an uncompleted fulltandem standing testing. Logistic and linear regression analyses were performed.
Results
Of the included 1,511 participants with prediabetes, 700 maintained as prediabetes, 306 progressed to diabetes, and 505 regressed to normoglycemia over 4 years. Grip strength and walking speed were declined from baseline during the 4-year followup, regardless of prediabetes status alteration. Compared with prediabetes maintenance, prediabetes progression increased the odds of developing weak grip strength by 89% (95% confidence interval [CI], 0.04 to 2.44) and exhibited larger declines in grip strength by 0.85 kg (95% CI, –1.65 to –0.04). However, prediabetes progression was not related to impairments in walking speed or standing balance. Prediabetes regression also did not affect any measures of physical function.
Conclusion
Prediabetes progression accelerates grip strength decline in aging population, while prediabetes regression may not prevent physical function decline due to aging.

Keyword

Aging; Follow-up studies; Hand strength; Prediabetic state

Figure

  • Fig. 1. Study design and flowchart. (A) Study design: considering the 4-year turn-around time in the Health and Retirement Study surveys, three sequential datasets were created, namely the pre-evaluation (data combined from 2008 and 2010 waves), baseline (data combined from 2012 and 2014 waves), and follow-up (data combined from 2016 and 2018 waves) datasets. The pre-evaluation dataset was used to identify participants with prediabetes, the baseline dataset was to ascertain prediabetes status alteration, and the follow-up dataset was to assess the impact of prediabetes status alteration on physical function. (B) Study flowchart: A total of 1,511 prediabetes participants aged >50 years from the pre-evaluation dataset were included. Among them, 1,227 participants with adequately functioning grip strength, 406 with adequately functioning walking speed, and 961 with adequately functioning standing balance were finally used for analyses on physical function during a 4-year follow-up. HbA1c, glycosylated hemoglobin.


Reference

1. Cooper R, Kuh D, Cooper C, Gale CR, Lawlor DA, Matthews F, et al. Objective measures of physical capability and subsequent health: a systematic review. Age Ageing. 2011; 40:14–23.
Article
2. Qiu S, Cai X, Zheng P, Yuan Y, Xu Y, Jia L, et al. Changes in objectively-measured physical capability over 4-year, risk of diabetes, and glycemic control in older adults: the China Health and Retirement Longitudinal study. Diabetes Res Clin Pract. 2022; 184:109186.
Article
3. Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019; 48:601.
Article
4. de Oliveira DC, de Oliveira Maximo R, Ramirez PC, de Souza AF, Luiz MM, Delinocente ML, et al. Is slowness a better discriminator of disability than frailty in older adults? J Cachexia Sarcopenia Muscle. 2021; 12:2069–78.
Article
5. Cooper R, Strand BH, Hardy R, Patel KV, Kuh D. Physical capability in mid-life and survival over 13 years of follow-up: British birth cohort study. BMJ. 2014; 348:g2219.
Article
6. Hostalek U. Global epidemiology of prediabetes: present and future perspectives. Clin Diabetes Endocrinol. 2019; 5:5.
7. Li Y, Teng D, Shi X, Qin G, Qin Y, Quan H, et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study. BMJ. 2020; 369:m997.
Article
8. Shang Y, Fratiglioni L, Vetrano DL, Dove A, Welmer AK, Xu W. Not only diabetes but also prediabetes leads to functional decline and disability in older adults. Diabetes Care. 2021; 44:690–8.
Article
9. Rooney MR, Rawlings AM, Pankow JS, Echouffo Tcheugui JB, Coresh J, Sharrett AR, et al. Risk of progression to diabetes among older adults with prediabetes. JAMA Intern Med. 2021; 181:511–9.
Article
10. Lazo-Porras M, Bernabe-Ortiz A, Ruiz-Alejos A, Smeeth L, Gilman RH, Checkley W, et al. Regression from prediabetes to normal glucose levels is more frequent than progression towards diabetes: the CRONICAS Cohort Study. Diabetes Res Clin Pract. 2020; 163:107829.
Article
11. Liu X, Wu S, Song Q, Wang X. Reversion from pre-diabetes mellitus to normoglycemia and risk of cardiovascular disease and all-cause mortality in a Chinese population: a prospective cohort study. J Am Heart Assoc. 2021; 10:e019045.
Article
12. Vistisen D, Kivimaki M, Perreault L, Hulman A, Witte DR, Brunner EJ, et al. Reversion from prediabetes to normoglycaemia and risk of cardiovascular disease and mortality: the Whitehall II cohort study. Diabetologia. 2019; 62:1385–90.
Article
13. Sonnega A, Faul JD, Ofstedal MB, Langa KM, Phillips JW, Weir DR. Cohort profile: the Health and Retirement Study (HRS). Int J Epidemiol. 2014; 43:576–85.
Article
14. Peterson MD, Casten K, Collins S, Hassan H, Garcia-Hermoso A, Faul J. Muscle weakness is a prognostic indicator of disability and chronic disease multimorbidity. Exp Gerontol. 2021; 152:111462.
Article
15. Bardenheier BH, Wu WC, Zullo AR, Gravenstein S, Gregg EW. Progression to diabetes by baseline glycemic status among middle-aged and older adults in the United States, 2006-2014. Diabetes Res Clin Pract. 2021; 174:108726.
Article
16. Kim ES, Kawachi I, Chen Y, Kubzansky LD. Association between purpose in life and objective measures of physical function in older adults. JAMA Psychiatry. 2017; 74:1039–45.
Article
17. American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2019. Diabetes Care. 2019; 42(Suppl 1):S13–28.
18. Duchowny KA, Peterson MD, Clarke PJ. Cut points for clinical muscle weakness among older Americans. Am J Prev Med. 2017; 53:63–9.
Article
19. Kitamura A, Seino S, Abe T, Nofuji Y, Yokoyama Y, Amano H, et al. Sarcopenia: prevalence, associated factors, and the risk of mortality and disability in Japanese older adults. J Cachexia Sarcopenia Muscle. 2021; 12:30–8.
Article
20. Yu R, Ong S, Cheung O, Leung J, Woo J. Reference values of grip strength, prevalence of low grip strength, and factors affecting grip strength values in Chinese adults. J Am Med Dir Assoc. 2017; 18:551.
Article
21. Perreault L, Temprosa M, Mather KJ, Horton E, Kitabchi A, Larkin M, et al. Regression from prediabetes to normal glucose regulation is associated with reduction in cardiovascular risk: results from the Diabetes Prevention Program outcomes study. Diabetes Care. 2014; 37:2622–31.
Article
22. de Abreu L, Holloway KL, Kotowicz MA, Pasco JA. Dysglycaemia and other predictors for progression or regression from impaired fasting glucose to diabetes or normoglycaemia. J Diabetes Res. 2015; 2015:373762.
Article
23. Pratte KA, Johnson A, Beals J, Bullock A, Manson SM, Jiang L, et al. Regression to normal glucose regulation in American Indians and Alaska natives of a diabetes prevention program. Diabetes Care. 2019; 42:1209–16.
Article
24. Tabak AG, Herder C, Rathmann W, Brunner EJ, Kivimaki M. Prediabetes: a high-risk state for diabetes development. Lancet. 2012; 379:2279–90.
Article
25. Wu F, Callisaya M, Laslett LL, Wills K, Zhou Y, Jones G, et al. Lower limb muscle strength is associated with poor balance in middle-aged women: linear and nonlinear analyses. Osteoporos Int. 2016; 27:2241–8.
Article
26. Qiu S, Cai X, Yuan Y, Xie B, Sun Z, Wang D, et al. Muscle strength and prediabetes progression and regression in middle-aged and older adults: a prospective cohort study. J Cachexia Sarcopenia Muscle. 2022; 13:909–18.
Article
27. Perreault L, Pan Q, Mather KJ, Watson KE, Hamman RF, Kahn SE, et al. Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study. Lancet. 2012; 379:2243–51.
Article
28. International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009; 32:1327–34.
29. Abellan van Kan G, Rolland Y, Andrieu S, Bauer J, Beauchet O, Bonnefoy M, et al. Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force. J Nutr Health Aging. 2009; 13:881–9.
Article
Full Text Links
  • DMJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr